1 – 10 of 41
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Predictive value of kallikrein forms and β-microseminoprotein in blood from patients with evidence of detectable levels of PSA after radical prostatectomy
(
- Contribution to journal › Article
- 2022
-
Mark
Independent validation of a pre-specified four-kallikrein marker model for prediction of adverse pathology and biochemical recurrence
(
- Contribution to journal › Article
- 2020
-
Mark
A pre-specified model based on four kallikrein markers in blood improves predictions of adverse pathology and biochemical recurrence after radical prostatectomy
(
- Contribution to journal › Article
- 2018
-
Mark
Long-term prediction of prostate cancer diagnosis and death using PSA and obesity related anthropometrics at early middle age : Data from the malmö preventive project
(
- Contribution to journal › Article
-
Mark
Feed-forward alpha particle radiotherapy ablates androgen receptor-addicted prostate cancer
(
- Contribution to journal › Article
- 2016
-
Mark
Reply to Re : The Memorial Sloan Kettering Cancer Center Recommendations for Prostate Cancer Screening
(
- Contribution to journal › Letter
-
Mark
The Memorial Sloan Kettering Cancer Center Recommendations for Prostate Cancer Screening
(
- Contribution to journal › Article
-
Mark
Author Reply
(
- Contribution to journal › Letter
-
Mark
Internalization of secreted antigen-targeted antibodies by the neonatal Fc receptor for precision imaging of the androgen receptor axis
(
- Contribution to journal › Article
- 2015
-
Mark
Improving the Specificity of Screening for Lethal Prostate Cancer Using Prostate-specific Antigen and a Panel of Kallikrein Markers: A Nested Case-Control Study.
(
- Contribution to journal › Article